pifithrin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steele, AJ | 1 |
| Prentice, AG | 1 |
| Hoffbrand, AV | 1 |
| Yogashangary, BC | 1 |
| Hart, SM | 1 |
| Nacheva, EP | 1 |
| Howard-Reeves, JD | 1 |
| Duke, VM | 1 |
| Kottaridis, PD | 1 |
| Cwynarski, K | 1 |
| Vassilev, LT | 1 |
| Wickremasinghe, RG | 1 |
1 other study available for pifithrin and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Benzothiazoles; Chlorambuc | 2008 |